Swedish Orphan Biovitrum AB (publ) (SWOBY)
Company Info
Highlights
$10.41B
$0.53
28.58
1.51
$26.03B
$20.24B
$12.11 - $17.20
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Swedish Orphan Biovitrum AB (publ), comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Swedish Orphan Biovitrum AB (publ) had a return of 18.82% year-to-date (YTD) and 16.05% in the last 12 months.
SWOBY
18.82%
2.36%
4.84%
16.05%
N/A
N/A
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of SWOBY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 21.96% | 18.82% | |||||||||||
| 2024 | 1.52% | -9.66% | 4.58% | 5.85% | 1.12% | 0.22% | -1.14% | 15.83% | 5.14% | -9.48% | -5.24% | -9.09% | -3.41% |
| 2023 | -91.10% | 2.32% | -56.25% | 76.32% | 27.01% | -0.24% | -19.76% | 24.78% | 5.47% | -90.60% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of SWOBY is 62, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Swedish Orphan Biovitrum AB (publ) (SWOBY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Swedish Orphan Biovitrum AB (publ) provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 |
|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.50 |
Dividend yield | 0.00% | 0.00% | 3.78% |
Monthly Dividends
The table displays the monthly dividend distributions for Swedish Orphan Biovitrum AB (publ). The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | ||||||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.50 | $0.00 | $0.00 | $0.00 | $0.50 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Swedish Orphan Biovitrum AB (publ). A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Swedish Orphan Biovitrum AB (publ) was 96.02%, occurring on Jun 30, 2023. The portfolio has not yet recovered.
The current Swedish Orphan Biovitrum AB (publ) drawdown is 89.22%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.02% | Apr 5, 2023 | 10 | Jun 30, 2023 | — | — | — |
Volatility
Volatility Chart
The current Swedish Orphan Biovitrum AB (publ) volatility is 17.27%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Swedish Orphan Biovitrum AB (publ) compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for SWOBY in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, SWOBY has a PE value of 28.6. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for SWOBY in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, SWOBY has a PEG value of 1.5. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Swedish Orphan Biovitrum AB (publ).
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |